BrainScanology

A System to Diagnose Brain Diseases

Company Information

Website:

https://www.brainscanology.com/

Sector:

Medical Facilities & Services

Location:

San Francisco, CA

BrainScanology is changing how MRIs are analyzed.

It’s developed a brain-disease diagnostic system. This system analyzes MRI brain scans to track the risks of neurological disorders including Bipolar Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD), dementia, and Alzheimer’s disease.

This company was founded by a computational biologist who invented a breakthrough method for analyzing colon cancer screenings. BrainScanology measures a brain’s area, volume, and shape, while the current system in use measures only a brain’s area and volume.

Notably, M&A activity in the medical imaging space includes some blockbuster deals. GE recently acquired Amersham PLC, a medical imaging company, for nine-and-a-half billion dollars. And in 2019, Fujifilm acquired Hitachi’s medical imaging business for one-and-a-half billion dollars.

Team Background

Dave Nguyen - Co-Founder & CEO
Harini Kumar - Co-Founder
William Jagust - Advisor

Co-Investors

Raising
$1.07 million
Committed
$88.15K (8%)
Current Valuation
$20 million Cap / 0% Discount
Min. Investment
$100
Deal Type
Title III
(For all investors)
Offering Type
SAFE
Finance History
Notable Investors
Learn more on WeFunder